On the other hand, our study did not demonstrate any statistically significant differences in protein expression in serum between astrocytoma grades and the control group, and no relationship of elevated MMP-2 protein expression with patient survival time. The gene discussed is MMP2; the disease is astrocytoma (excluding glioblastoma).